Search This Blog

Wednesday, February 27, 2019

Collegium Pharmaceutical reports Q4 EPS 27c, consensus (35c)

Reports Q4 revenue $73.4M, consensus $73.86M. Net income for the 2018 Quarter was $9.1M, or 27c per share (basic and diluted, compared to net loss of $17.4 million, or 54c per share,basic and diluted, for the 2017 Quarter. Net income (loss) included stock-based compensation expense of $3.6 million and $2.1 million for the 2018 Quarter and 2017 Quarter, respectively.
https://thefly.com/landingPageNews.php?id=2871565

No comments:

Post a Comment

Note: Only a member of this blog may post a comment.